Adlard, P., and Vickers, J. (2002). Morphologically distinct plaque types differentially affect dendritic structure and organisation in the early and late stages of Alzheimer’s disease. Acta Neuropathol. 103, 377–383. doi: 10.1007/s00401-001-0476-6
Alarcón, J. M., Malleret, G., Touzani, K., Vronskaya, S., Ishii, S., Kandel, E. R., et al. (2004). Chromatin acetylation, memory, and LTP are impaired in CBP+/- mice: a model for the cognitive deficit in Rubinstein-Taybi syndrome and its amelioration. Neuron 42, 947–959. doi: 10.1016/j.neuron.2004.05.021
Bloss, E. B., Cembrowski, M. S., Karsh, B., Colonell, J., Fetter, R. D., and Spruston, N. (2016). Structured Dendritic Inhibition Supports Branch-Selective Integration in CA1 Pyramidal Cells. Neuron 89, 1016–1030. doi: 10.1016/j. neuron.2016.01.029
Citron, M. (2010). Alzheimer’s disease: strategies for disease modification. Nat. Rev. Drug Discov. 9, 387–398. doi: 10.1038/nrd2896
Cummings, J. L. (2009). Defining and labeling disease-modifying treatments for Alzheimer’s disease. Alzheimers Dement. 5, 406–418. doi: 10.1016/j.jalz.2008. 12.003
Cutsuridis, V., and Poirazi, P. (2015). A computational study on how theta modulated inhibition can account for the long temporal windows in the entorhinal-hippocampal loop. Neurobiol. Learn. Mem. 120, 69–83. doi: 10. 1016/j.nlm.2015.02.002
De Simone, A., La Pietra, V., Betari, N., Petragnani, N., Conte, M., Daniele, S., et al. (2019). Discovery of the First-in-Class GSK-3β/HDAC Dual Inhibitor as
Disease-Modifying Agent To Combat Alzheimer’s Disease. ACS Med. Chem. Lett. 10, 469–474. doi: 10.1021/acsmedchemlett.8b00507
Falke, E., Nissanov, J., Mitchell, T. W., Bennett, D. A., Trojanowski, J. Q., and Arnold, S. E. (2003). Subicular Dendritic Arborization in Alzheimer’s Disease Correlates with Neurofibrillary Tangle Density. Am. J. Pathol. 163, 1615–1621. doi: 10.1016/S0002-9440(10)63518-3
Fischer, A., Sananbenesi, F., Wang, X., Dobbin, M., and Tsai, L.-H. (2007). Recovery of learning and memory is associated with chromatin remodelling. Nature 447, 178–182. doi: 10.1038/nature05772
Gojo, I., Jiemjit, A., Trepel, J. B., Sparreboom, A., Figg, W. D., Rollins, S., et al. (2007). Phase 1 and pharmacologic study of MS-275, a histone deacetylase inhibitor, in adults with refractory and relapsed acute leukemias. Blood 109, 2781–2790. doi: 10.1182/blood-2006-05-021873
Gonzalez-Zuñiga, M., Contreras, P. S., Estrada, L. D., Chamorro, D., Villagra, A., Zanlungo, S., et al. (2014). c-Abl Stabilizes HDAC2 Levels by Tyrosine Phosphorylation Repressing Neuronal Gene Expression in Alzheimer’s Disease. Mol. Cell 56, 163–173. doi: 10.1016/j.molcel.2014.08.013
Gräff, J., Rei, D., Guan, J.-S., Wang, W.-Y., Seo, J., Hennig, K. M., et al. (2012). An epigenetic blockade of cognitive functions in the neurodegenerating brain. Nature 483, 222–226. doi: 10.1038/nature10849
Grueber, W. B., and Sagasti, A. (2010). Self-avoidance and tiling: mechanisms of dendrite and axon spacing. Cold Spring Harb. Perspect. Biol. 2:a001750. doi: 10.1101/cshperspect.a001750
Grutzendler, J., Helmin, K., Tsai, J., and Gan, W.-B. (2007). Various dendritic abnormalities are associated with fibrillar amyloid deposits in Alzheimer’s disease. Ann. N. Y. Acad. Sci. 1097, 30–39. doi: 10.1196/annals.13 79.003
Guan, J.-S., Haggarty, S. J., Giacometti, E., Dannenberg, J.-H., Joseph, N., Gao, J., et al. (2009). HDAC2 negatively regulates memory formation and synaptic plasticity. Nature 459, 55–60. doi: 10.1038/nature07925
Hausser, M., Spruston, N., and Stuart, G. J. (2000). Diversity and dynamics of dendritic signaling. Science 290, 739–744. doi: 10.1126/science.290.54 92.739
Heideman, M. R., Lancini, C., Proost, N., Yanover, E., Jacobs, H., and Dannenberg, J. H. (2014). Sin3a-associated Hdac1 and Hdac2 are essential for hematopoietic stem cell homeostasis and contribute differentially to hematopoiesis. Haematologica 99, 1292–1303. doi: 10.3324/haematol.2013. 092643
Horch, H. W., and Katz, L. C. (2002). BDNF release from single cells elicits local dendritic growth in nearby neurons. Nat. Neurosci. 5, 1177–1184. doi: 10.1038/ nn927
Klausberger, T., and Somogyi, P. (2008). Neuronal diversity and temporal dynamics: the unity of hippocampal circuit operations. Science 321, 53–57. doi: 10.1126/science.1149381
Kohara, K., Pignatelli, M., Rivest, A. J., Jung, H.-Y., Kitamura, T., Suh, J., et al. (2014). Cell type–specific genetic and optogenetic tools reveal hippocampal CA2 circuits. Nat. Neurosci. 17, 269–279. doi: 10.1038/nn.3614
Korzus, E., Rosenfeld, M. G., and Mayford, M. (2004). CBP Histone Acetyltransferase Activity Is a Critical Component of Memory Consolidation. Neuron 42, 961–972. doi: 10.1016/j.neuron.2004.06.002
LeDoux, J. E. (2000). Emotion circuits in the brain. Annu. Rev. Neurosci. 23, 155–184. doi: 10.1146/annurev.neuro.23.1.155
Leuner, B., Falduto, J., and Shors, T. J. (2003). Associative Memory Formation Increases the Observation of Dendritic Spines in the Hippocampus. J. Neurosci. 23, 659–665. doi: 10.1523/JNEUROSCI.23-02-00659.2003
Lynch, M. A. (2004). Long-term potentiation and memory. Physiol. Rev. 84, 87–136. doi: 10.1152/physrev.00014.2003
Malthankar-Phatak, G., Poplawski, S., Toraskar, N., and Siman, R. (2012). Combination therapy prevents amyloid-dependent and - independent structural changes. Neurobiol. Aging 33, 1273–1283. doi: 10.1016/j.neurobiolaging.2010.12.007
Marks, P. A., and Xu, W. S. (2009). Histone deacetylase inhibitors: potential in cancer therapy. J. Cell. Biochem. 107, 600–608. doi: 10.1002/jcb.22185
Nakano, Y., Kondoh, G., Kudo, T., Imaizumi, K., Kato, M., Miyazaki, J., et al. (1999). Accumulation of murine amyloidbeta42 in a gene-dosage-dependent manner in PS1 “knock-in” mice. Eur. J. Neurosci. 11, 2577–2581. doi: 10.1046/j.1460-9568.1999.00698.x
Nasrallah, K., Therreau, L., Robert, V., Huang, A. J. Y., McHugh, T. J., Piskorowski, R. A., et al. (2019). Routing Hippocampal Information Flow through Parvalbumin Interneuron Plasticity in Area CA2. Cell Rep. 27, 86–98.e3. doi: 10.1016/j.celrep.2019.03.014
Nott, A., Watson, P. M., Robinson, J. D., Crepaldi, L., and Riccio, A. (2008). S-nitrosylation of histone deacetylase 2 induces chromatin remodelling in neurons. Nature 455, 411–415. doi: 10.1038/nature07238
Paulson, J. B., Ramsden, M., Forster, C., Sherman, M. A., McGowan, E., and Ashe, K. H. (2008). Amyloid Plaque and Neurofibrillary Tangle Pathology in a Regulatable Mouse Model of Alzheimer’s Disease. Am. J. Pathol. 173, 762–772. doi: 10.2353/ajpath.2008.080175
Penney, J., and Tsai, L.-H. (2014). Histone deacetylases in memory and cognition. Sci. Signal. 7:re12. doi: 10.1126/scisignal.aaa0069
Perez-Cruz, C., Nolte, M. W., Van Gaalen, M. M., Rustay, N. R., Termont, A., Tanghe, A., et al. (2011). Reduced spine density in specific regions of CA1 pyramidal neurons in two transgenic mouse models of Alzheimer’s disease. J. Neurosci. 31, 3926–3934. doi: 10.1523/JNEUROSCI.6142-10.2011
Poirazi, P., and Mel, B. W. (2001). Impact of active dendrites and structural plasticity on the memory capacity of neural tissue. Neuron 29, 779–796. doi: 10.1016/S0896-6273(01)00252-5
Prince, H. M., Bishton, M. J., and Harrison, S. J. (2009). Clinical Studies of Histone Deacetylase Inhibitors. Clin. Cancer Res. 15, 3958–3969. doi: 10.1158/1078- 0432.CCR-08-2785
Qing, H., He, G., Ly, P. T. T., Fox, C. J., Staufenbiel, M., Cai, F., et al. (2008). Valproic acid inhibits aβ production, neuritic plaque formation, and behavioral deficits in alzheimer’s disease mouse models. J. Exp. Med. 205, 2781–2789. doi: 10.1084/jem.20081588
Ricobaraza, A., Cuadrado-Tejedor, M., and Garcia-Osta, A. (2011). Long-term phenylbutyrate administration prevents memory deficits in Tg2576 mice by decreasing Abeta. Front. Biosci. 3, 1375–1384. doi: 10.2741/e340
Ricobaraza, A., Cuadrado-Tejedor, M., Marco, S., Pérez-Otaño, I., and García-Osta, A. (2012). Phenylbutyrate rescues dendritic spine loss associated with memory deficits in a mouse model of Alzheimer disease. Hippocampus 22, 1040–1050. doi: 10.1002/hipo.20883
Ricobaraza, A., Cuadrado-Tejedor, M., Pérez-Mediavilla, A., Frechilla, D., Del
Río, J., and García-Osta, A. (2009). Phenylbutyrate ameliorates cognitive deficit and reduces tau pathology in an Alzheimer’s disease mouse model. Neuropsychopharmacology 34, 1721–1732. doi: 10.1038/npp.2008.229
Šišková, Z., Justus, D., Kaneko, H., Friedrichs, D., Henneberg, N., Beutel, T., et al. (2014). Dendritic Structural Degeneration Is Functionally Linked to Cellular Hyperexcitability in a Mouse Model of Alzheimer’s Disease. Neuron 84, 1023–1033. doi: 10.1016/j.neuron.2014.10.024
Spruston, N. (2008). Pyramidal neurons: dendritic structure and synaptic integration. Nat. Rev. Neurosci. 9, 206–221. doi: 10.1038/nr n2286
Sung, Y. M., Lee, T., Yoon, H., DiBattista, A. M., Song, J. M., Sohn, Y., et al. (2013). Mercaptoacetamide-based class II HDAC inhibitor lowers Aβ levels and improves learning and memory in a mouse model of Alzheimer’s disease. Exp. Neurol. 239, 192–201. doi: 10.1016/j.expneurol.2012. 10.005
Takeuchi, A., Irizarry, M. C., Duff, K., Saido, T. C., Ashe, K. H., Hasegawa, M., et al. (2000). Age-related amyloid β deposition in transgenic mice overexpressing both alzheimer mutant presenilin 1 and amyloid β precursor protein swedish mutant is not associated with global neuronal loss. Am. J. Pathol. 157, 331–339. doi: 10.1016/S0002-9440(10)64544-0
Taniguchi, M., Carreira, M. B., Cooper, Y. A., Bobadilla, A.-C., Heinsbroek, J. A., Koike, N., et al. (2017). HDAC5 and Its Target Gene, Npas4, Function in the Nucleus Accumbens to Regulate Cocaine-Conditioned Behaviors. Neuron 96, 130–144.e6. doi: 10.1016/j.neuron.2017.09.015
Vecsey, C. G., Hawk, J. D., Lattal, K. M., Stein, J. M., Fabian, S. A., Attner, M. A., et al. (2007). Histone Deacetylase Inhibitors Enhance Memory and Synaptic Plasticity via CREB: CBP-Dependent Transcriptional Activation. J. Neurosci. 27, 6128–6140. doi: 10.1523/JNEUROSCI.0296-07.2007
Vila-Luna, S., Cabrera-Isidoro, S., Vila-Luna, L., Juárez-Díaz, I., Bata-García, J. L., Alvarez-Cervera, F. J., et al. (2012). Chronic caffeine consumption prevents cognitive decline from young to middle age in rats, and is associated with increased length, branching, and spine density of basal dendrites in CA1 hippocampal neurons. Neuroscience 202, 384–395. doi: 10.1016/j.neuroscience. 2011.11.053
Wang, D. B., Kinoshita, C., Kinoshita, Y., Sopher, B. L., Uo, T., Lee, R. J., et al. (2019). Neuronal susceptibility to beta-amyloid toxicity and ischemic injury involves histone deacetylase-2 regulation of endophilin-B1. Brain Pathol. 29, 164–175. doi: 10.1111/bpa.12647
Yamaguchi, T., Cubizolles, F., Zhang, Y., Reichert, N., Kohler, H., Seiser, C., et al. (2010). Histone deacetylases 1 and 2 act in concert to promote the G1-to-S progression. Genes Dev. 24, 455–469. doi: 10.1101/gad.552310
論文の公開元へ
